SILEXION THERAPEUTICS CORP Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
SILEXION THERAPEUTICS CORP (SLXN) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $44.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $44.00K.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $291.00K.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.60M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.98M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $44.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $291.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $2.60M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $6.98M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $120.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $2.59M 10-Q · filed 2026-08-14 | -$2.59M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$3.99M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$4.58M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $153.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $1.61M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $3.00M S-1/A · filed 2026-08-10 | |
| 2023-09-30 | -$4.65M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $5.42M 10-Q · filed 2024-11-14 | -$5.42M 10-Q · filed 2024-08-29 |
| 2023-03-31 | $6.86M 10-Q · filed 2024-08-29 | |
| 2022-12-31 | $7.57M 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |